참고문헌
- Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-3072. https://doi.org/10.1200/JCO.2007.15.4377
- Ferrone CR, Tang LH, Tomlinson J, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 2007;25:5609-5615. https://doi.org/10.1200/JCO.2007.12.9809
- Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008;113:2655-2664. https://doi.org/10.1002/cncr.23883
- Ito T, Sasano H, Tanaka M, et al. Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 2010;45:234-243. https://doi.org/10.1007/s00535-009-0194-8
- Oberg K. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Ann N Y Acad Sci 1994;733:46-55. https://doi.org/10.1111/j.1749-6632.1994.tb17255.x
- Moyana TN. Gastrointestinal endocrine cells and carcinoids: histogenetic and pathogenetic considerations. Pathol Annu 1995;30(Pt 1):227-246.
- Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934-959. https://doi.org/10.1002/cncr.11105
- Mani S, Modlin IM, Ballantyne G, Ahlman H, West B. Carcinoids of the rectum. J Am Coll Surg 1994;179:231-248.
- Godwin JD 2nd. Carcinoid tumors: an analysis of 2,837 cases. Cancer 1975;36:560-569. https://doi.org/10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4
- Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997;79:813-829.
- Bosman FT; World Health Organization; International Agency for Research on Cancer. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon: International Agency for Research on Cancer, 2010.
- Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007;451:757-762. https://doi.org/10.1007/s00428-007-0452-1
- Ramage JK, Davies AH, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Gut 2005;54 Suppl 4:iv1-iv16.
- Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours: a consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004;80:394-424. https://doi.org/10.1159/000085237
- Oberg K, Jelic S; ESMO Guidelines Working Group. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and followup. Ann Oncol 2009;20 Suppl 4:150-153.
- Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms): part II-specific NE tumour types. Acta Oncol 2004;43:626-636. https://doi.org/10.1080/02841860410018584
- Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms): part I-general overview. Acta Oncol 2004;43:617-625. https://doi.org/10.1080/02841860410018575
- Lim T, Lee J, Kim JJ, et al. Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea. Asia Pac J Clin Oncol 2011;7:293-299. https://doi.org/10.1111/j.1743-7563.2011.01423.x
- Gastrointestinal Pathology Study Group of Korean Society of Pathologists, Cho MY, Kim JM, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study. Cancer Res Treat 2012;44:157-165. https://doi.org/10.4143/crt.2012.44.3.157
- Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395-401. https://doi.org/10.1007/s00428-006-0250-1
- Scarpa A, Mantovani W, Capelli P, et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 2010;23:824-833. https://doi.org/10.1038/modpathol.2010.58
- Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008;95:627-635. https://doi.org/10.1002/bjs.6051
- Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008;14:7798-7803. https://doi.org/10.1158/1078-0432.CCR-08-0734
- Lee H, Choi J, An JS, et al. The clinicopathological characteristics of gastrointestinal neuroendocrine tumors: an analysis of 65 cases. Korean J Pathol 2007;41:149-157.
- Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005;12:1083-1092. https://doi.org/10.1677/erc.1.01017
- Pape UF, Berndt U, Muller-Nordhorn J, et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2008;15:1083-1097. https://doi.org/10.1677/ERC-08-0017
- Rothenstein J, Cleary SP, Pond GR, et al. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital. Am J Clin Oncol 2008;31:64-70. https://doi.org/10.1097/COC.0b013e31807a2f49
- Grama D, Eriksson B, Martensson H, et al. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg 1992;16:632-639. https://doi.org/10.1007/BF02067341
- Shebani KO, Souba WW, Finkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg 1999;229:815-821. https://doi.org/10.1097/00000658-199906000-00008
- Sutton R, Doran HE, Williams EM, et al. Surgery for midgut carcinoid. Endocr Relat Cancer 2003;10:469-481. https://doi.org/10.1677/erc.0.0100469
- Colonoscopy Study Group of Korean Society of Coloproctology. Clinical characteristics of colorectal carcinoid tumors. J Korean Soc Coloproctol 2011;27:17-20. https://doi.org/10.3393/jksc.2011.27.1.17
피인용 문헌
- Proper Treatment Option for Small Rectal Neuroendocrine Tumors Using Precut Endoscopic Mucosal Resection vol.50, pp.6, 2017, https://doi.org/10.5946/ce.2017.182
- Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience vol.19, pp.12, 2017, https://doi.org/10.31557/apjcp.2018.19.12.3597
- Everolimus for the treatment of advanced gastrointestinal or lung nonfunctional neuroendocrine tumors in East Asian patients: a subgroup analysis of the RADIANT-4 study vol.12, pp.None, 2019, https://doi.org/10.2147/ott.s182259
- Clinical analysis of 547 patients with neuroendocrine tumors in a Chinese population: A single‐center study vol.8, pp.8, 2017, https://doi.org/10.1002/cam4.2259
- Clinicopathological Study of 100 Cases of Neuroendocrine Neoplasms of the Gastroenteropancreatic System: A Tertiary Cancer Center Experience vol.41, pp.3, 2020, https://doi.org/10.4103/ijmpo.ijmpo_217_18